New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Novo Nordisk A/S

NVO

Healthcare Drug Manufacturers General

Novo Nordisk A/S’s revenue for fiscal 2025 (year ended December 2025) was $46.8 billion, up 11.1% from fiscal 2024.

Revenue
+3.87%
EPS
−17.1%
Free cash flow
−14.8%
Total debt
+30.7%

Quarter to September 2026, against a year earlier

38.57 0.32 −0.82%
Market cap
$128.6B
P/E
9.8×
Fwd P/E FY26e
—
Dividend yield
4.62%
F-score
5/9
ROIC
29.6%
Net debt / EBITDA
0.7×
Payout ratio
0.5×

Novo Nordisk A/S (NVO) P/E ratio

Alert me on P/E ratio

As of Nov 19, 2026, Novo Nordisk A/S (NVO) trades at a P/E ratio of 9.8×. Over the past ten years it has ranged from 8.6× (April 2026) to 50.7× (June 2024); the current reading is higher than 2% of that period. That is below the Drug Manufacturers General industry median of 25.3× and below the Healthcare sector median of 22.4×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 14.7× (43.92%)
FY2024 26.1× (30.74%)
FY2023 37.7× (4.36%)
FY2022 39.5× 16.65%
FY2021 33.8× 33.20%
FY2020 25.4× 7.97%
FY2019 23.5× 29.18%
FY2018 18.2× (21.64%)
FY2017 23.2× 44.31%
FY2016 16.1× (44.26%)

Quarterly newest first

Period P/E ratio Change
Sep 2026 9.5× (18.53%)
Jun 2026 11.7× 35.87%
Mar 2026 8.6× (41.17%)
Dec 2025 14.7× (9.10%)
43 more quarters

Against its own ten years

Low 8.6× High 50.7×
Ten-year median 25.4×
Current reading's percentile 2

P/E ratio against peers

Company P/E ratio
GILD Gilead Sciences, Inc. compare n/m
NVO Novo Nordisk A/S 9.8×
BMY Bristol Myers Squibb Company compare 12.9×
GSK GSK PLC Sponsored ADR compare 16.4×
SNY Sanofi compare 22.8×
AZN AstraZeneca PLC compare 24.6×
AMGN Amgen Inc. compare 25.2×
NVS Novartis AG compare 28.8×
PFE Pfizer Inc. compare 38.8×
Drug Manufacturers General industry median 25.3×
Healthcare sector median 22.4×
Market median 16.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on NVO